Envestnet Asset Management
DERM icon

Envestnet Asset Management’s Journey Medical DERM Stock Holding History

Envestnet Asset Management’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$466K Sell
65,825
-5,811
-8% -$33.2K ﹤0.01% 4133
2026
Q1 		$336K Buy
71,636
+38,042
+113% +$295K ﹤0.01% 4209
2025
Q4 		$259K Sell
33,594
-27,356
-45% -$214K ﹤0.01% 4127
2025
Q3 		$434K Sell
60,950
-9,041
-13% -$65.6K ﹤0.01% 3864
2025
Q2 		$503K Sell
69,991
-33,162
-32% -$229K ﹤0.01% 3681
2025
Q1 		$609K Sell
103,153
-404
-0.4% -$1.99K ﹤0.01% 3500
2024
Q4 		$405K Sell
103,557
-6,029
-6% -$32.9K ﹤0.01% 3707
2024
Q3 		$619K Sell
109,586
-21,985
-17% -$113K ﹤0.01% 3414
2024
Q2 		$742K Buy
131,571
+102,596
+354% +$422K ﹤0.01% 3217
2024
Q1 		$107K Buy
+28,975
New +$126K ﹤0.01% 4053

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAIM
Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Envestnet Asset Management's DERM Position: Q2 2026 in Review

Envestnet Asset Management reduced its Journey Medical (DERM) stake by 8.1% in Q2 2026, selling an estimated $33.2K and leaving 65,825 shares worth $466K. The position accounts for ﹤0.01% of the portfolio, ranked #4133.

Envestnet Asset Management first reported a position in DERM in Q1 2024 and has held it in 10 quarters since. The position peaked at $742K in Q2 2024. 71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

  • Envestnet Asset Management held 65,825 shares of Journey Medical worth $466K as of Q2 2026.
  • Envestnet Asset Management sold 5,811 Journey Medical shares in Q2 2026, an estimated $33.2K.
  • Journey Medical made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #4133 holding.
  • Envestnet Asset Management first reported a position in Journey Medical in Q1 2024 and has held it in 10 quarters since.
  • Envestnet Asset Management's Journey Medical position peaked at $742K in Q2 2024.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.